Tipo |
Título / Nombre |
Autor(es) |
Año |
|
Identificación del cáncer de mama y ovario hereditario desde determinaciones moleculares en el tumor |
González Santiago S |
2019 |
|
Replied to "Some remarks to SEOM clinical guidelines on cardiovascular toxicity (2018)" |
Virizuela JA, García AM, de Las Peñas R, Santaballa A, Andrés R..., González-Santiago S, Fernández TL |
2019 |
|
SEOM clinical guidelines on cardiovascular toxicity (2018) |
Virizuela JA, García AM, de Las Peñas R, Santaballa A, Andrés R..., González-Santiago S, Fernández TL |
2019 |
|
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer |
Romero I, Mallol P, Santaballa A, Del Campo JM, Mori M, González-Santiago S, Casado A, Vicente D, Ortega E, Herrero A, Guerra E, Barretina-Ginesta P, Rubio MJ, Martínez A, Bover I14, Vidal L15, Arcusa Á, Martín L, García Y, González-Martín A |
2019 |
|
Treatment and long-term clinical outcomes of incidental pulmonary embolism in cancer patients: an international prospective cohort study |
Kraaijpoel N, Bleker SM, van Es N, Mahé L, Muñoz A, Meyer G, Planquette B, Sánchez O, Bertoletti L, Accasat S, Magalhaes de E, Baars J, Rutten A, Lalezari F, Beyer-Westendorf J, Endig S, Marten S, Porreca E, Rutjes AW, Russi I, Constans J, Boulon C, Kleinjan A, Beenen LFM, Iosub D, Piovella F, Couturaud F, Tromeur C, Biosca M, Assaf JD, HelfermH, Pinson M, Lerede T, Falanga A, Lacroix P, Désormais I, Maraveyas A, Bozas G, Aggarwal A, Rickles F, Girard P, Caliandro R, Martínez del Prado P, Prado Maneiro de C, García Escobar I, González Santiago S, Schmidt J, Dublanchet N, Aquilanti S, Confrere E, Paleirón N, Grange C, Sevestre MA, Ferrer Pérez AI, Salgado Fernández M, Falvo N, Thaler J, Otten HM, Carrier M, Bergmann JF, Büller HR, Di Nisio M |
2018 |
|
Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer |
Colombo N, Huang G, Scambia G, Chalas E, Pignata S, Fiorica J, Van Le L, Ghamande S, González-Santiago S, Bover I, Graña Suárez B, Green A, Huot-Marchand P, Bourhis Y, Karve S, Blakeley C |
2018 |
|
Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain |
Esteban I, Vilaró M, Adrover E, Angulo A, Carrasco E, Gadea N, Sánchez A, Ocaña T, Llort G, Jover R, Cubiella J, Servitja S, Herráiz M, Cid L, Martínez S, Oruezábal-Moreno MJ, Garau I, Khorrami S, Herreros-de-Tejada A, Morales R, Cano JM, Serrano R, López-Ceballos MH, González-Santiago S, Juan-Fita MJ, Alonso-Cerezo C, Casas A, Graña B, Teulé A, Alba E, Antón A, Guillén-Ponce C, Sánchez-Heras AB, Alés-Martínez JE, Brunet J, Balaguer F, Balmaña J |
2018 |
|
Massive Pulmonary Embolism in Oncological Patient with Cetuximab Treatment: Hipercoagulability Status in Cancer Patients - A Case Report and a Review of Scientific Literature |
Illan A, Aires J, Ayala P, Gorospe I, Muñoz J, Quintana L,
, Collado R, Rodríguez MA, Borrega P, López de Ceballos MH,
, González S, Alonso S, García-Escobar I |
2017 |
|
Estudio de prevalencia del Cáncer de Ovario, Peritoneal o de Trompa de Falopio Hereditario en población española |
González Santiago S, Romero S, López-Ceballos MH, Alonso S, Macías R, García JA, Aires J, Corcho M, Fernández L, Borrega P |
2017 |
|
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial |
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomaševi? Z, Denduluri N, Šeparovi? R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A, González Santiago S, [ ExteNET Study Group ] |
2017 |